Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more than half, according to a study published in Critical Care Nurse.

Baylor Scott & White The Heart Hospital-Plano in Texas cut times of cardiogenic shock diagnosis in half after implementing a quality improvement project that included nurse education and an ...

Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, ...

The book focuses on providing key practical information on treatment techniques for busy CUU personnel and features some important topics such as shock, sever sepsis, echocardiography, catheter-based ...

SCAI Stage C cardiogenic shock is characterized by significant ... in earlier studies by improving systolic blood pressure ...

Windtree Therapeutics (WINT) announced that Alexandre Mebazaa, MD, one of the world’s recognized leaders in cardiogenic shock, gave a ...

Danvers: Johnson & Johnson MedTech, has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...

Mechanical circulatory supports (MCS) are used increasingly to sustain patients with severe, acute cardiac and pulmonary failure. Indications have been broadened to include severe influenza and ...